SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : BCRX: Target practice for shorts
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Swami who wrote (51)8/25/1999 2:41:00 PM
From: Wolff   of 96
 
don't know, sorry, can truly said I wish I knew, I remain unconvinced of the science and believe that the Analyst is not being straight about here recommendations. I don't expect the SEC to do much, but I will spend some more time on that effort.

Roche almost has a drug out from FDA final approval expected in October, and Glaxo does have one done. By the time BCRX product is done, it could be over the counter time, considering how supposedly well tolerated these NA inhibitors are.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News